VIRTUAL POSTER ROOM GCOS 2021

The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy.

"If a poster fails to open, click the download link in the window to access the content"



Metformin attenuates the cardiotoxicity of ibrutinib through AMPK and PI3K-Akt pathway

Pengsha Li, Ming Yuan, Daiqi Liu, Bingxin Xie, Guangping Li MD PhD, Gary Tse MD FRCP FACC, Tong Liu MD PhD FESC

Leave a Reply

Your email address will not be published. Required fields are marked *

Blockade of the innate immune checkpoint CD47 decreases infarct size by modulation of oxidative stress and immune response

S. Korste, P. Stock, U. Hendgen-Cotta, T. Rassaf, M. Totzeck

Leave a Reply

Your email address will not be published. Required fields are marked *

Can pyridoxamine tackle anthracycline-induced cardiotoxicity?

Sibren Haesen, Aline Brillouet, Iris de Laat, Lotte Vastmans, Lize Evens, Sarah D’Haese, Esther Wolfs, Dorien Deluyker, Virginie Bito

Leave a Reply

Your email address will not be published. Required fields are marked *

RhoA/ROCK pathway participates in the study of related mechanisms of apatinib in the treatment of breast cancer-induced hypertension

Wenjuan Wang, Haodong zhang, Qiongying Wang, Chenchen Zhuang, Xin Fan, Caie Li, Runmin Sun, Miaomiao Qi

Leave a Reply

Your email address will not be published. Required fields are marked *


Use Of Strain-encoded Magnetic Resonance Imaging During Chemotherapy Is Associated With Improved Left Ventricular Function And Reduced Adverse Cardiovascular Events

Felix D. Nguyen MD, Srilakshmi Vallabhaneni MD, Kaitlin Moore BS, Olivia Passafiume MS, Mary P Watkins BS, Pamela K. Woodard MD, Gregory M. Lanza MD, Daniel J. Lenihan MD

Leave a Reply

Your email address will not be published. Required fields are marked *

Cancer Therapy Related Cardiac Dysfunction

Sheela Sawant, Anuprita Daddi , Amey Bedekar

Leave a Reply

Your email address will not be published. Required fields are marked *

Cardiovascular adverse events in patients treated with anthracyclines during induction therapy for acute myeloid leukemia (AML) a systematic review and meta-analysis

Jesse Geels, Anna van Rhenen, Folkert W. Asselbergs, Marijke Linschoten

Leave a Reply

Your email address will not be published. Required fields are marked *

Chemotherapy-related cardiac dysfunction in breast cancer patients treated with doxorubicin, cyclophosphamide, paclitaxel with or without trastuzumab - a systematic review and meta-analysis

Louise V. Dübel, Rhodé M. Bijlsma, Janine Kamphuis, Arco J. Teske, Janine Kamphuis, Folkert W. Asselbergs, Marijke Linschoten

Leave a Reply

Your email address will not be published. Required fields are marked *

Left ventricular diastolic function in patients with breast cancer treated with anthracyclines – a meta-analysis

Raluca I. Mincu, PhD; Lena Lampe; Tienush Rassaf, MD; Matthias Totzeck, MD

Leave a Reply

Your email address will not be published. Required fields are marked *

Predective factors of cardiotoxicy in lymphoma patients receiving antrhacilines in frontline

A.LOPEZ-GARCIA , E. MACIA, S. GOMEZ TALAVERA, M. OREJAS, B. IBAÑEZ, E. CASTILLO, D. MORILLO, MA. PEREZ, E. ASKARI, P. LLAMAS, ,R. CORDOBA

Leave a Reply

Your email address will not be published. Required fields are marked *

Cancer Patients with Potential Eligibility for Anthracyclines Have an Increased Risk for Heart Failure

Sun, Shuyuan Zhang, Mengyan Dai, Yanli Zhang, Yunlong Xia, Ling Yiu

Leave a Reply

Your email address will not be published. Required fields are marked *

A Novel Diagnostic Approach for the Detection of Cardiac Dysfunction from Breast Cancer Therapy Validation Study with Cardiovascular Magnetic Resonance

Maryam MD; Camila M. Urzua Fresno, MD; Emily Somerset MSc; Tamar Shalmon MD; Eitan Amir MD PhD; Chun-Po Steve Fan PhD; Christine Brezden-Masley MD, PhD; Babitha Thampinathan RDCS, Yobiga Thevakumaran RN; Kibar Yared MD; C. Anne Koch MD PhD; Husam Abdel-Qadir MD, PhD; Anna Woo, MD, SM; Paul Yip, PhD; Thomas H. Marwick MD, PhD, MPH; Rosanna Chan BSc; Bernd J. Wintersperger MD; Paaladinesh Thavendiranathan MD, SM

Leave a Reply

Your email address will not be published. Required fields are marked *


Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction

Lars Michel; Ulrike B. Hendgen-Cotta; Raluca I. Mincu; Iris Helfrich; Sebastian Korste; Simone M. Mrotzek; Armin Spomer; Christoph Rischpler; Ken Herrmann; Lale Umutlu; Elisabeth Livingstone; Selma Ugurel; Lisa Zimmer; Cristina Coman; Robert Ahrends; Matthias Gunzer; Dirk Schadendorf; Tienush Rassaf; Matthias Totzeck

Leave a Reply

Your email address will not be published. Required fields are marked *

Left ventricular global longitudinal strain reduction in patients with melanoma and extracardiac immune-related adverse events during immune checkpoint inhibitor therapy

Raluca I. Mincu; Julia Pohl; Simone Mrotzek; Lars Michel; Lena Hinrichs; Lena Lampe; Tienush Rassaf; Matthias Totzeck

Leave a Reply

Your email address will not be published. Required fields are marked *

Immune-associated Myocarditis in Patients Receiving Camrelizumab -A single-center retrospective study

Chuan Zhang, Zhong Zuo, Zhulu Chen, Diansha Gao, Chunhua Mo, Yuxi Zhu, Shu Qin

Leave a Reply

Your email address will not be published. Required fields are marked *

Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) inhibitors and adverse cardiovascular events: A population-based study

Sharen Lee, Jiandong Zhou , Ishan Lakhani , Lei Yang MD PhD, Tong Liu MD PhD, Yuhui Zhang MD PhD, Yunlong Xia MD PhD FACC, Wing Tak Wong PhD, Kelvin King Hei Bao MB Bchir FRCR, Ian Chi Kei Wong PhD, Gary Tse MD FRCP, FACC, Qingpeng Zhang PhD

Leave a Reply

Your email address will not be published. Required fields are marked *


Development of heart failure in hematopoietic stem cell transplant patients

Fernández de Sanmamed Girón M., Bautista García J., Ramonis Quintero J., Galván Ruiz M., Aguiar Bermudez B., Peña Ortega P., Torres Ochando M., González Pinedo L., López Pérez M., Groba Marco M., Mendoza Lemes H., García Quintana A., Perera Alvarez M., Caballero Dorta E.

Leave a Reply

Your email address will not be published. Required fields are marked *

Are there cardiological differences between autologous and allogenic Hematopoietic stem cell transplantation?

Fernández de Sanmamed Girón M., Aguiar Bermudez B., Ramonis Quintero J., Galván Ruiz M., Bautista García J., Peña Ortega P., Torres Ochando M., González, Pinedo L., López Pérez M., Groba Marco M., Mendoza Lemes H., García Quintana A., Perera Alvarez M., Caballero Dorta E.

Leave a Reply

Your email address will not be published. Required fields are marked *

Left ventricular dysfunction after Hematopoetic Cell Transplantation

Priscila Nasser de Carvalho, Mauro Jorge Freitas de Souza Junior

Leave a Reply

Your email address will not be published. Required fields are marked *


Cardiac biomarkers among men with metastatic castration-resistant prostate cancer during abiraterone acetate treatment – a prospective, single centre study.

Michał Wilk, Anna Waśko-Grabowska, Sebastian Szmit

Leave a Reply

Your email address will not be published. Required fields are marked *

Identification of baseline cardiovascular co-morbidities and risk factors in prostate cancer patients receiving Androgen Deprivation Therapy: RWD from UK primary care

Dr Sivatharshini Ramalingam, Dr Patrick Davey, Dr Maria Sol Andres, Jay Were, Dr Simon Wan Yau Ming and Professor Stuart Rosen

Leave a Reply

Your email address will not be published. Required fields are marked *


5-Flourouracil-related Cardiomyopathy and Management Strategy

Taha Ahmed, MD, Amit Arbune, MD, MHA, FACC

Leave a Reply

Your email address will not be published. Required fields are marked *

Risk Predictors for Fluoropyrimidine Cardiotoxicity: A Large Retrospective Institutional Analysis

AT Abiodun, M Shawe-Taylor, S Tybally, T Bajomo, S Slater, N Diamantis, C Manisty

Leave a Reply

Your email address will not be published. Required fields are marked *


Myocardial tissue contractility as an indicator of cardiac function post radiation therapy

El-Sayed H. Ibrahim, Luba Frank, Carmen Bergom

Leave a Reply

Your email address will not be published. Required fields are marked *

Thoracic irradiation leads to endothelial damage and differential immune response in mice

Simone M. Mrotzek, Florian Wirsdörfer, Sebastian Korste, Lars Michel, Lena Gockeln, Ulrike Hendgen-Cotta, Verena Jendrossek, Tienush Rassaf, Matthias Totzeck

Leave a Reply

Your email address will not be published. Required fields are marked *

Cardiovascular Risk and Prevention Strategies in Chinese Patients with Breast Cancer Treated with Radiotherapy: A Retrospectively Study

Yanjun Zhou, Xin Liu, Yule Hu, Haojie Yang, Tao Liang*

Leave a Reply

Your email address will not be published. Required fields are marked *

Safe Delivery of Radiotherapy in Patients with Cancer and CIEDs

Cehic Daniela, Eckert Marionb, Corsini Nadiab, Sharplin Gregb, Tran Phuonga

Leave a Reply

Your email address will not be published. Required fields are marked *


Cardio-Oncology Registry in Opole (CORO)

Marek Kania

Leave a Reply

Your email address will not be published. Required fields are marked *

Establishment of a cardio-oncology center: Clinical practice and decision-making

Simone M. Mrotzek, Alina Röll, Raluca-I. Mincu, Tienush Rassaf, Matthias Totzeck

Leave a Reply

Your email address will not be published. Required fields are marked *

CARDIOTOXICITY SURVEILLANCE: UNCOVERING A “HIDDEN” DISEASE

Saraiva, M.; Moura, AR.; Castilho, B.; Veiga, R.; Craveiro, N.; Domingues, K.; Pitta, ML.; Martins, V.

Leave a Reply

Your email address will not be published. Required fields are marked *

Sailing in the mist: cardiotoxicity monitoring in adolescent and young adult osteosarcoma patients

JC Heemelaar, AAM al Jaff, RE Evenhuis, ES Polomski, MAJ van de Sande, AJ Gelderblom, FM Speetjens, ML Antoni

Leave a Reply

Your email address will not be published. Required fields are marked *


Ivabradine to prevent anthracycline-induced cardiotoxicity: an ongoing prospective randomized, open-label clinical trial

Eglė Čiburienė, Greta Ščerbickaitė, Edita Baltruškevičienė, Monika Drobnienė, Jelena Čelutkienė, Sigita Aidietienė

Leave a Reply

Your email address will not be published. Required fields are marked *

Angiotensin II Receptor Blocker vs. Calcium Channel Blocker in the Treatment of Bevacizumab induced Hypertension: Comparison of Serum VEGF level

Boda Zhou M.D., Zhuo Yu M.D., Ping Zhang M.D.

Leave a Reply

Your email address will not be published. Required fields are marked *


Ibrutinib induced rhythm disorders- does inflammation play a role?

Iva Minga MD, Charile Robin, Iliana Spitz, Jason Robin MD

Leave a Reply

Your email address will not be published. Required fields are marked *

Intravascular leiomyomatosis with intracardiac extension: role for medical management

Dr Ryan Panchal, Dr Alexander Lyon, Dr Maria Sol Andres

Leave a Reply

Your email address will not be published. Required fields are marked *

Sacubitril/valsartan significant positive effect in a patient with chemotherapy associated heart failure

J. Safonova, I. Ilgisonis, M. Kozhevnikova, D. Budanova, Yu. Naimann, E. Privalova, YU. Belenkov

Leave a Reply

Your email address will not be published. Required fields are marked *

An Unusual Case of Toxicity Related to 5-FU Chemotherapy

George Lolay MD, Atul R Chugh MD, Ryan Daly, Meghana Raghavendra MD, and Vijay U Rao MD PhD

Leave a Reply

Your email address will not be published. Required fields are marked *

Predictive value of high-sensitive troponin T ratio in breast cancer treatment

Sergey Kozhukhov, Nataliia Dovganych, Ivan Smolanka, Olga Lygyrda

Leave a Reply

Your email address will not be published. Required fields are marked *

Acute Coronary Syndrome Secondary to Cisplatin in a Patient with Bladder Cancer: A Case Report.

AH Hernandez-Pineda, MD; N Garcia-Hernandez, MD; JD Hernandez-Guzman, MD; SA Montoya-Guerrero, MD; JF Antezana-Castro, MD; M Carillo-Estrada, MD

Leave a Reply

Your email address will not be published. Required fields are marked *

DOACs: a new skyline in cancer-associated thrombosis resistant to heparin. A case of seminoma in BEP Chemotherapy solved with edoxaban

Agnese Maria Fioretti, Tiziana Leopizzi, Giovanni Luzzi, Vito Lorusso, Stefano Oliva

Leave a Reply

Your email address will not be published. Required fields are marked *

A CARdiac Case: CD19-targeting Chimeric Antigen Receptor (CAR)-T in Primary Mediastinal B-Cell Lymphoma (PMBCL)

Chen D H, Low R, Clark S, Thomson K, Bishton M, Walker J M, Manisty C, Ghosh A K, O’Reilly M, Roddie C

Leave a Reply

Your email address will not be published. Required fields are marked *

MRI reveals progression of cardiovascular function post chemotherapy in sarcoma

El-Sayed H. Ibrahim, John Charlson

Leave a Reply

Your email address will not be published. Required fields are marked *

Acute Pericarditis follow by Transient Myocarditis: A case of immune checkpoint inhibitor related cardiotoxicity in a 63-year-old female

Ammar Hasnie, MD, Usman Hasnie, MD, Courtney Estes, CRNP, Aparna Hegde, MD, Carrie Lenneman, MD

Leave a Reply

Your email address will not be published. Required fields are marked *

A rare case of severe heart failure from pemetrexed

Marina Macedo Kuenzer Bond, José Eduardo M. Barbosa, Waldinai P. Ferreira, Júlio Cesar Santin, Carlos G. de Paula Jr, Humberto João Rigon Jr, Marcelo Corassa

Leave a Reply

Your email address will not be published. Required fields are marked *

Successful drug rechallenge after osimertinib-related acute cardiac failure

Marina Macedo Kuenzer Bond, José Ecio Batista Rosado Jr, José Eduardo M. Barbosa, , Waldinai P. Ferreira, Júlio Cesar Santin, Carlos G. de Paula Jr, Humberto João Rigon Jr, Helano Carioca Freitas

Leave a Reply

Your email address will not be published. Required fields are marked *

The use of sacubitril-valsartan in a patient with anti-her2 cardiotoxicity enabling rapid recovery and re-exposure: a case report

Marina Macedo Kuenzer Bond, José Eduardo M. Barbosa, Waldinai P. Ferreira, Júlio Cesar Santin, Carlos G. de Paula Jr, Humberto Rigon Jr, Fabiana Baroni A.Makdissi, Maria Nirvana da C. Formiga

Leave a Reply

Your email address will not be published. Required fields are marked *

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [288.64 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [897.03 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [889.09 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [14.06 MB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [2.86 MB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [3.02 MB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [215.45 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [505.57 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [310.66 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [580.62 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [130.81 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [841.46 KB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [1.23 MB]

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download Broucher [753.24 KB]